{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:24:07Z","timestamp":1792859047970,"version":"4.5.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"DOI":"10.1186\/s12903-026-08320-8","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T07:07:28Z","timestamp":1776236848000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Elevated expression of JAK1 and pJAK1 in oral lichen planus: a retrospective study"],"prefix":"10.1186","volume":"26","author":[{"given":"Puangwan","family":"Lapthanasupkul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nakarin","family":"Kitkumthorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tawepong","family":"Arayapisit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintana","family":"Pankam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siribang-on Piboonniyom","family":"Khovidhunkit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nattha","family":"Rattanasiriphan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dulyapong","family":"Rungraungrayabkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"issue":"2","key":"8320_CR1","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1001\/jamadermatol.2019.3797","volume":"156","author":"C Li","year":"2020","unstructured":"Li C, Tang X, Zheng X, Ge S, Wen H, Lin X, et al. Global Prevalence and Incidence Estimates of Oral Lichen Planus: A Systematic Review and Meta-analysis. JAMA Dermatol. 2020;156(2):172\u201381. https:\/\/doi.org\/10.1001\/jamadermatol.2019.3797.","journal-title":"JAMA Dermatol"},{"key":"8320_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4103\/1735-3327.351344","volume":"19","author":"Z Saberi","year":"2022","unstructured":"Saberi Z, Tabesh A, Darvish S. Oral health-related quality of life in erosive\/ulcerative oral lichen planus patients. Dent Res J (Isfahan). 2022;19:55.","journal-title":"Dent Res J (Isfahan)"},{"issue":"2","key":"8320_CR3","doi-asserted-by":"publisher","first-page":"CD001168","DOI":"10.1002\/14651858.CD001168.pub3","volume":"2","author":"G Lodi","year":"2020","unstructured":"Lodi G, Manfredi M, Mercadante V, Murphy R, Carrozzo M. Interventions for treating oral lichen planus: corticosteroid therapies. Cochrane Database Syst Rev. 2020;2(2):CD001168. https:\/\/doi.org\/10.1002\/14651858.CD001168.pub3.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"8320_CR4","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1111\/odi.14142","volume":"29","author":"A El-Howati","year":"2023","unstructured":"El-Howati A, Thornhill MH, Colley HE, Murdoch C. Immune mechanisms in oral lichen planus. Oral Dis. 2023;29(4):1400\u201315. https:\/\/doi.org\/10.1111\/odi.14142.","journal-title":"Oral Dis"},{"issue":"10","key":"8320_CR5","doi-asserted-by":"publisher","first-page":"e0164080","DOI":"10.1371\/journal.pone.0164080","volume":"11","author":"AK Alves de Medeiros","year":"2016","unstructured":"Alves de Medeiros AK, Speeckaert R, Desmet E, Van Gele M, De Schepper S, Lambert J. JAK3 as an Emerging Target for Topical Treatment of Inflammatory Skin Diseases. PLoS ONE. 2016;11(10):e0164080. https:\/\/doi.org\/10.1371\/journal.pone.0164080.","journal-title":"PLoS ONE"},{"issue":"1","key":"8320_CR6","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu X, Li J, Fu M, Zhao X, Wang W. The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduct Target Ther. 2021;6(1):402. https:\/\/doi.org\/10.1038\/s41392-021-00791-1.","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"8320_CR7","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1111\/ddg.14612","volume":"19","author":"NR Kooybaran","year":"2021","unstructured":"Kooybaran NR, Petzold G, Strobel P, Schon MP, Mossner R. Alleviation of erosive oral and esophageal lichen planus by the JAK1 inhibitor upadacitinib. J Dtsch Dermatol Ges. 2021;19(12):1778\u201380. https:\/\/doi.org\/10.1111\/ddg.14612.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"9","key":"8320_CR8","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1034\/j.1600-0714.2003.00125.x","volume":"32","author":"EH van der Meij","year":"2003","unstructured":"van der Meij EH, van der Waal I. Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications. J Oral Pathol Med. 2003;32(9):507\u201312. https:\/\/doi.org\/10.1034\/j.1600-0714.2003.00125.x.","journal-title":"J Oral Pathol Med"},{"issue":"6","key":"8320_CR9","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1016\/j.jaci.2020.01.031","volume":"145","author":"W Damsky","year":"2020","unstructured":"Damsky W, Wang A, Olamiju B, Peterson D, Galan A, King B. Treatment of severe lichen planus with the JAK inhibitor tofacitinib. J Allergy Clin Immunol. 2020;145(6):1708\u2013e17101702. https:\/\/doi.org\/10.1016\/j.jaci.2020.01.031.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"8320_CR10","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.jaad.2024.01.060","volume":"90","author":"LC Chen","year":"2024","unstructured":"Chen LC, Ogbutor C, Kelley KJ, Senna MM. Topical tofacitinib for patients with lichen planopilaris and\/or frontal fibrosing alopecia. J Am Acad Dermatol. 2024;90(6):1260\u20132. https:\/\/doi.org\/10.1016\/j.jaad.2024.01.060.","journal-title":"J Am Acad Dermatol"},{"key":"8320_CR11","doi-asserted-by":"publisher","unstructured":"Ociepa K, Danilewicz M, Wagrowska-Danilewicz M, Peterson-Jeckowska R, Wojcicka-Rubin A, Lewkowicz N, et al. Expression of the Selected Proteins of JAK\/STAT Signaling Pathway in Diseases with Oral Mucosa Involvement. Int J Mol Sci. 2022;24(1). https:\/\/doi.org\/10.3390\/ijms24010323.","DOI":"10.3390\/ijms24010323"},{"issue":"4","key":"8320_CR12","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jaad.2016.12.005","volume":"76","author":"W Damsky","year":"2017","unstructured":"Damsky W, King BA. JAK inhibitors in dermatology: The promise of a new drug class. J Am Acad Dermatol. 2017;76(4):736\u201344. https:\/\/doi.org\/10.1016\/j.jaad.2016.12.005.","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"8320_CR13","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1002\/eji.201646680","volume":"47","author":"K Welsch","year":"2017","unstructured":"Welsch K, Holstein J, Laurence A, Ghoreschi K. Targeting JAK\/STAT signalling in inflammatory skin diseases with small molecule inhibitors. Eur J Immunol. 2017;47(7):1096\u2013107. https:\/\/doi.org\/10.1002\/eji.201646680.","journal-title":"Eur J Immunol"},{"key":"8320_CR14","doi-asserted-by":"publisher","first-page":"1333986","DOI":"10.3389\/fphar.2023.1333986","volume":"14","author":"L Zhao","year":"2023","unstructured":"Zhao L, Chen J, Bai B, Song G, Zhang J, Yu H, et al. Topical drug delivery strategies for enhancing drug effectiveness by skin barriers, drug delivery systems and individualized dosing. Front Pharmacol. 2023;14:1333986. https:\/\/doi.org\/10.3389\/fphar.2023.1333986.","journal-title":"Front Pharmacol"},{"key":"8320_CR15","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3389\/fimmu.2020.00344","volume":"11","author":"T Fetter","year":"2020","unstructured":"Fetter T, Smith P, Guel T, Braegelmann C, Bieber T, Wenzel J. Selective Janus Kinase 1 Inhibition Is a Promising Therapeutic Approach for Lupus Erythematosus Skin Lesions. Front Immunol. 2020;11:344. https:\/\/doi.org\/10.3389\/fimmu.2020.00344.","journal-title":"Front Immunol"},{"issue":"8","key":"8320_CR16","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1016\/j.jid.2022.01.015","volume":"142","author":"CM Brumfiel","year":"2022","unstructured":"Brumfiel CM, Patel MH, Severson KJ, Zhang N, Li X, Quillen JK, et al. Ruxolitinib Cream in the Treatment of Cutaneous Lichen Planus: A Prospective, Open-Label Study. J Invest Dermatol. 2022;142(8):2109\u2013e21162104. https:\/\/doi.org\/10.1016\/j.jid.2022.01.015.","journal-title":"J Invest Dermatol"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-026-08320-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-026-08320-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-026-08320-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T02:00:56Z","timestamp":1781834456000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12903-026-08320-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8320"],"URL":"https:\/\/doi.org\/10.1186\/s12903-026-08320-8","relation":{},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the Faculty of Dentistry\/Faculty of Pharmacy, Mahidol University, Institutional Review Board (COA.No.MU-DT\/PY-IRB 2022\/008.1403). The requirement for informed consent was waived by the Institutional Review Board of the Faculty of Dentistry\/Faculty of Pharmacy, Mahidol University, because archived specimens were used and no identifiable patient information was accessed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1079"}}